PSUSA/00002688/202503
PSUSA/00002688/202503
PSUSA/00002688/202503
PSUSA/00002656/202502
Emer Cooke, EMA’s Executive Director: 2025 achievements in medicine regulation
EMA Management Board: highlights of December 2025 meeting
EMA business hours over holiday period
Human medicines European public assessment report (EPAR): Yargesa, miglustat, Date of authorisation: 22/03/2017, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Simulect, basiliximab, Date of authorisation: 09/10/1998, Revision: 30, Status: Authorised
PSUSA/00002640/202503
Human medicines European public assessment report (EPAR): Methylthioninium chloride Proveblue, methylthioninium chloride, Date of authorisation: 06/05/2011, Revision: 30, Status: Authorised
PSUSA/00002039/202503